Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Synthetic Biologics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Synthetic Biologics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Synthetic Biologics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Synthetic Biologics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Synthetic Biologics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Synthetic Biologics Inc, Pharmaceuticals & Healthcare, Deal Details 13
Asset Purchase 13
Synthetic Biologics Completes Acquisition Of C. difficile Infectious Disease Program Of Prev AbR 13
Venture Financing 15
SeeChange Health Raises US$3 Million In Venture Financing 15
Partnerships 16
Synthetic Biologics Enters into Research Agreement with Centers for Disease Control and Prevention 16
Intrexon Enters into Partnership with Synthetic Biologics 17
Synthetic Biologics and Enterome Bioscience Enter into Research Agreement 18
Synthetic Biologics Exapnds its Agreement With Intrexon To Develop Monoclonal Antibodies For Infectious Diseases 19
Licensing Agreements 20
Synthetic Biologics Enters Into Licensing Agreement With Cedars-Sinai Medical Center 20
Equity Offering 22
Synthetic Biologics Plans to Raise up to USD200 Million in Public Offering of Shares 22
Synthetic Biologics Raises USD12 Million in Private Placement of Series A Preferred Shares 23
Synthetic Biologics Raises USD25 Million in Public Offering of Common Stock and Warrants 24
Synthetic Biologics Raises USD46 Million in Public Offering of Shares 26
Synthetic Biologics Raises USD20.7 Million in Private Placement of Units 28
Synthetic Biologics Completes Public Offering Of Shares For US$13.2 Million 30
Synthetic Biologics Completes Private Placement Of Common Stock For US$11 Million 31
Acquisition 32
Hartlab Acquires Adeona Clinical Lab From Synthetic Biologics 32
Synthetic Biologics Inc – Key Competitors 33
Synthetic Biologics Inc – Key Employees 34
Synthetic Biologics Inc – Locations And Subsidiaries 35
Head Office 35
Other Locations & Subsidiaries 35
Recent Developments 36
Financial Announcements 36
Aug 08, 2018: Synthetic Biologics reports second quarter 2018 operational highlights and financial results 36
May 08, 2018: Synthetic Biologics Reports First Quarter 2018 Operational Highlights And Financial Results 37
Feb 22, 2018: Synthetic Biologics Reports 2017 Year End Operational Highlights and Financial Results 39
Nov 01, 2017: Synthetic Biologics Reports Third Quarter 2017 Operational Highlights and Financial Results 40
Aug 03, 2017: Synthetic Biologics Reports Second Quarter 2017 Operational Highlights and Financial Results 41
May 04, 2017: Synthetic Biologics Reports First Quarter 2017 Operational Highlights and Financial Results 43
Mar 02, 2017: Synthetic Biologics Reports 2016 Year End Operational Highlights and Financial Results 45
Corporate Communications 47
May 22, 2018: Synthetic Biologics Announces Acceptance of Compliance Plan by NYSE American 47
Mar 07, 2018: Synthetic Biologics Reports on NYSE American Noncompliance Notice and Compliance Plan 48
Dec 05, 2017: Synthetic Biologics Announces Management Changes 49
Product News 50
01/18/2017: Synthetic Biologics Confirms Key Features of Pivotal Phase 2b/3 Trial of SYN-010 Pursuant to Consultations with FDA 50
Clinical Trials 51
Apr 19, 2017: Synthetic Biologics Reports Preclinical Data Demonstrating SYN-005 Provides Protection from Pertussis in Neonatal Animal Study 51
Appendix 53
Methodology 53
About GlobalData 53
Contact Us 53
Disclaimer 53
Synthetic Biologics Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Synthetic Biologics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Synthetic Biologics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Synthetic Biologics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Synthetic Biologics Inc, Deals By Therapy Area, 2012 to YTD 2018 9
Synthetic Biologics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Synthetic Biologics Completes Acquisition Of C. difficile Infectious Disease Program Of Prev AbR 13
SeeChange Health Raises US$3 Million In Venture Financing 15
Synthetic Biologics Enters into Research Agreement with Centers for Disease Control and Prevention 16
Intrexon Enters into Partnership with Synthetic Biologics 17
Synthetic Biologics and Enterome Bioscience Enter into Research Agreement 18
Synthetic Biologics Exapnds its Agreement With Intrexon To Develop Monoclonal Antibodies For Infectious Diseases 19
Synthetic Biologics Enters Into Licensing Agreement With Cedars-Sinai Medical Center 20
Synthetic Biologics Plans to Raise up to USD200 Million in Public Offering of Shares 22
Synthetic Biologics Raises USD12 Million in Private Placement of Series A Preferred Shares 23
Synthetic Biologics Raises USD25 Million in Public Offering of Common Stock and Warrants 24
Synthetic Biologics Raises USD46 Million in Public Offering of Shares 26
Synthetic Biologics Raises USD20.7 Million in Private Placement of Units 28
Synthetic Biologics Completes Public Offering Of Shares For US$13.2 Million 30
Synthetic Biologics Completes Private Placement Of Common Stock For US$11 Million 31
Hartlab Acquires Adeona Clinical Lab From Synthetic Biologics 32
Synthetic Biologics Inc, Key Competitors 33
Synthetic Biologics Inc, Key Employees 34
Synthetic Biologics Inc, Subsidiaries 35
List of Figures
Synthetic Biologics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Synthetic Biologics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Synthetic Biologics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Synthetic Biologics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Synthetic Biologics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Synthetic Biologics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Synthetic Biologics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Synthetic Biologics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9